TREATMENT OF SOCIAL PHOBIA

社交恐惧症是一种普遍存在但知之甚少的焦虑症 以强烈焦虑的经历为特征， 避免在社交场合受到他人的审视。 社会 恐惧症不仅会导致高度的主观痛苦， 也可能导致孤独，降低学术和职业 业绩，职业和个人发展受限，酒精 虐待和抑郁 与其他焦虑症一样， 社交恐惧症的特征是躯体（身体） 感觉）、认知（思想）和外显行为（回避） 功能. 关于社交恐惧症治疗的信息远远落后于此 其他恐惧症的症状 两种截然不同的治疗方法，药物 β-肾上腺素能阻滞剂治疗和行为 脱敏疗法都显示出相当大的 保证 然而，没有公开的尝试， 比较这两种治疗方法，或者检查它们的组合 有效治疗社交恐惧症。 这项研究是一项治疗比较脱敏 加上安慰剂，β受体阻滞剂阿替洛尔， 脱敏和阿替洛尔以及安慰剂。 一百八十 受试者将参加3个月的治疗期， 个月随访阶段。 结果将允许评估 阿替洛尔的有效性，脱敏，和潜在的 阿替洛尔加脱敏的协同组合。 此外，这些处理的耐久性将是 测定 这项研究将提供重要信息， 社交恐惧症的临床管理以及这些 社会和全球功能的治疗。

Social phobia is a prevalent yet poorly understood anxiety disorder characterized by the experience of intense anxiety in, and often avoidance of social situations involving scrutiny by others. Social phobia not only leads to a high degree of subjective distress, but also can result in loneliness, reduced academic and vocational performance, restricted career and personal development, alcohol abuse and depression. As in other anxiety disorders, the anxiety experienced by social phobics is characterized by somatic (bodily sensations), cognitive (thoughts), and overt behavior (avoidance) features. Information on the treatment of social phobia lags far behind that of other phobic conditions. Two very different treatments, drug treatment with beta-adrenergic blocking agents and behavior therapy with desensitization both have shown considerable promise. However, there has been no published attempt to compare these two treatments, or to examine their combined effectiveness in treating social phobia. The proposed study is a treatment comparison of desensitization plus placebo, the beta-blocking drug atenolol, combined desensitization and atenolol, and placebo. One hundred and eighty subjects will participate in a 3 month treatment phase and a 6 month follow-up phase. The results will allow an assessment of the effectiveness of atenolol, desensitization, and the potentially synergistic combination of atenolol plus desensitization. Furthermore, the durability of these treatments will be determined. This study will provide important information on the clinical management of social phobia and the impact of these treatments on social and global functioning.